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Development of Multiple-Locus Variable Number Tandem
Repeat Analysis for the molecular subtyping of Enterobacter
sakazakii. 
Abstract
The genomic content of Enterobacter sakazakii strain ATCC BAA-894 was analyzed for
variable-number tandem  repeats (VNTRs). In this study we report the development of a multiple-locus
VNTR analysis (MLVA) strategy for  the subtyping of E. sakazakii. The method is based on a
GeneScan analysis of four VNTR loci labeled with multiple  fluorescent dyes. This approach was
applied to a collection of 112 isolates representing all 16 of the currently defined  E. sakazakii
biogroups. MLVA successfully discriminated among these isolates and compared favorably with 
pulsed-field gel electrophoresis. The method was relatively fast and easy to perform. The potential value
of MLVA  as an epidemiological tool is discussed.
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The genomic content of Enterobacter sakazakii strain ATCC BAA-894 was analyzed for variable-number tandem
repeats (VNTRs). In this study we report the development of a multiple-locus VNTR analysis (MLVA) strategy for
the subtyping of E. sakazakii. The method is based on a GeneScan analysis of four VNTR loci labeled with multiple
fluorescent dyes. This approach was applied to a collection of 112 isolates representing all 16 of the currently defined
E. sakazakii biogroups. MLVA successfully discriminated among these isolates and compared favorably with
pulsed-field gel electrophoresis. The method was relatively fast and easy to perform. The potential value of MLVA
as an epidemiological tool is discussed.
Enterobacter sakazakii is an emerging opportunistic patho-
gen that is the cause of rare cases of meningitis, necrotizing
enterocolitis, and bacteremia in infants (1, 2, 9, 29, 40, 43).
High mortality rates have been reported among those who
develop meningitis, with the infants often presenting clinical
complications, such as brain abscesses, seizures, and infarction
(18). E. sakazakii, originally described as a “yellow-pigmented”
coliform, first appeared in the literature in 1958 following a
fatal case of infant meningitis in England (39). Since then,
cases of infant infection have been reported from all regions of
the developing world, with over 111 illness events and at least
26 deaths currently documented (27).
Based on genotyping and biotyping studies, E. sakazakii rep-
resents a diverse and taxonomically ill-defined species (11, 13,
14, 20). Iversen et al., (12) recently proposed the reclassifica-
tion of the species into a new genus comprised of five species.
Although clinical and domestic sources have been docu-
mented, the most frequently implicated mode of transmission
of this bacterium is through consumption of contaminated
powdered infant formula (4, 7, 26, 35, 40).
The ability to identify routes of transmission in cases of E.
sakazakii infection relies on the availability of reproducible, highly
discriminatory techniques for the purposes of surveillance and
outbreak investigation. Strain subtyping by molecular methods is
of particular interest. Ribotyping, random amplification of poly-
morphic DNA, and pulsed-field gel electrophoresis (PFGE) are
methods that have been used to subtype E. sakazakii (5, 8, 28, 30,
37). In our laboratory, we showed that XbaI macrorestriction,
followed by PFGE analysis, gives good discrimination and is
highly reproducible (28). Although PFGE has been successfully
applied to investigate E. sakazakii outbreaks (5, 37), the method
has recognized limitations and may be superseded in the future by
more modern approaches.
The availability of a complete E. sakazakii genome sequence
(http://genome.wustl.edu/pub/organism/Microbes/Enteric_Bacteria
/Enterobacter_sakazakii/assembly/Enterobacter_sakazakii-4.0/) pro-
vided the opportunity to search the genome for variable-num-
ber tandem-repeat (VNTR) motifs, which represent sources of
genetic polymorphisms that, when suitably applied, can be
used as a basis for subtyping. VNTRs consist of DNA elements
that are repeated in tandem (41). The sequence element is
often maintained within a bacterial species, with individual
strains displaying different copy numbers. The length of a tan-
dem repeat (TR) at a specific locus can vary as a consequence
of DNA polymerase slippage during replication or unequal
crossover events. These differences can be analyzed by ampli-
fication of the region and sizing of the resulting amplicons (15).
The high degree of polymorphism at these loci has proven
particularly useful as a target for strain discrimination of bac-
terial species. Multiple-locus variable-number TR analysis
(MLVA) is a subtyping method that involves amplification and
fragment size analysis of polymorphic VNTR regions. It has
been successfully used to type other Enterobacteriaceae, includ-
ing Salmonella (6, 23, 25, 33, 38), Escherichia coli (16, 21, 24,
32), and Yersinia pestis (17, 19). MLVA is a rapid method of
high discriminatory power that is easily standardized between
laboratories (22).
This study describes the development of an MLVA subtyp-
ing scheme and its application to a genotypically and pheno-
typically diverse collection of E. sakazakii isolates. To our
knowledge, this is the first report of the application of MLVA
to subtype E. sakazakii.
MATERIALS AND METHODS
Bacterial strains. A summary of the E. sakazakii strains used in the present
study is shown in Table 1. A global collection of 112 isolates was selected to
represent the phenotypic, genetic, and epidemiologic diversity of E. sakazakii.
The isolates included both domestic strains (35) and strains from the United
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Kingdom, France, Switzerland, Denmark, The Netherlands, the Czech Republic,
the United States, Canada, Malaysia, Pakistan, Indonesia, Korea, and New
Zealand. These strains represent all currently known biogroups (13). All isolates
were confirmed as E. sakazakii by real-time PCR using a primer set and probe
targeting the dnaG gene on the macromolecular synthesis operon (34). All
bacteria were cultured on nutrient agar (Oxoid, Basingstoke, United Kingdom),
and for long-term storage, the isolates were maintained in cryopreservation fluid
at 80°C (Technical Service Consultants Ltd., Lancashire, England).
Genomic-DNA extraction. Briefly, all bacteria were cultured on nutrient agar
at 37°C for 18 h, and an isolated colony was then inoculated into 10 ml tryptone
soy broth (Oxoid). One milliliter of overnight culture was recovered by centrif-
ugation at 13,000 to 16,000  g for 2 min. Total DNA was prepared using the






Country Source Country Source
CFS01 Ireland Milk-processing facilitya 1 112 Unknown Unknown 1
CFS06 Ireland Milk-processing facilitya 1 195 Unknown Unknown 1
CFS07 Ireland Milk-processing facilitya 1 336 Unknown Unknown 2
CFS09 Ireland Milk-processing facilitya 1 338 Unknown Unknown 5
CFS10 Ireland Milk-processing facilitya 5 343 Unknown Unknown 1
CFS101 Ireland PIF facilityb 2 344 Unknown Unknown 1
CFS104 Ireland PIF facilityc 2 E265 Malaysia Milk powder 5
CFS108 Ireland PIF facilityb 2 E290 Switzerland PIF facilityb 2
CFS110 Ireland PIF facilityb 2 E465 Pakistan PIF facilityb 6
CFS115 Ireland PIF facilityb 2 E515 Switzerland Water 10
CFS116 Ireland PIF facilityb 8 E604 Canada Clinical 1
CFS122 Ireland PIF facilityb 2 E616 Unknown Food 15
CFS127 Ireland PIF facilitya 2 E625 Korea Infant food 16
CFS128 Ireland PIF facilityc 2 E626 Korea Infant food 16
CFS129 Ireland PIF facilityb 5 E632 United States Infant food 2 or 4
CFS130 Ireland PIF facilitya 8 E681 Unknown Infant food 16
CFS131 Ireland PIF facilitya 1 E685 Unknown Food 14
CFS135 Ireland PIF facilityb 8A E694 Unknown Food 16
CFS136 Ireland PIF facilityb 8 E760 Czech Republic Clinical 3
CFS138 Ireland PIF facilityb 2 E765 Czech Republic Clinical 9
CFS139 Ireland PIF facilityb 2 E770 Denmark Milk powder 2
CFS148 Ireland PIF facilityb 8 E772 France Milk powder 5
CFS150 Ireland PIF facilityb 8A E775 Russia Milk powder 13
CFS152 Ireland PIF facilityb 2 E777 Netherlands Milk powder 2
CFS155 Ireland PIF facilityb 2 E784 Netherlands Neonate 2
CFS156 Ireland PIF facilityb 1 E786 Netherlands Neonate 1
CFS158 Ireland PIF facilityb 2 E787 Netherlands Neonate 1
CFS167 Ireland PIF facilityb 8A E789 Netherlands Neonate 2
CFS170 Ireland PIF facilityb 2 E808 Indonesia Milk powder 2
CFS173 Ireland PIF facilitya 8 E809 Indonesia Milk powder 1
CFS174 Ireland PIF facilityb 3 E825 (CDC 1058-77) United States Human (breast abscess) 9
CFS175 Ireland PIF facilityb 1 E827 (CDC 407-77) United States Human (septum) 4
CFS176 Ireland PIF facilityb 1 E828 (CDC 3128-77) United States Human (septum) 11
CFS237 Ireland PIF facilityb 12 E829 (CDC 1716-77) United States Human (blood) 9
CFS1001 Ireland PIF facilitya 2 E830 (CDC 9369-75) United States Unknown 7
206N New Zealand Milk powder 1 E834 France Neonate (feces) 1
207N New Zealand Milk powder 1 E837 France Neonate (feces) 4
228N New Zealand Milk powder 1 E844 France Neonate (feces) 4
229N New Zealand Milk powder 1 E846 France Neonate (feces) 1
254N New Zealand Milk powder 2 E866 Switzerland Neonate 16
302N New Zealand Milk powder 1 E888 Denmark Milk powder 15
305N New Zealand Milk powder 2 E892 United States Clinical 3
37 Unknown Unknown 1 E893 United States Clinical 8
44 Unknown Unknown 1 E899 United States Clinical 1
50 Unknown Unknown 1 E900 United States Clinical 1
53 Unknown Unknown 1 E901 United States Clinical 3
71 Unknown Unknown 1 NCTC 29004 United States Unknown 1
73 Unknown Unknown 1 NCTC 11467 United States Human (throat) 1
80 Unknown Unknown 1 NCTC 8155 United Kingdom Milk powder 1
82 Unknown Unknown 1 ATCC 12868 Unknown Unknown 1
88 Unknown Unknown 2 ATCC 51329 Unknown Unknown 15
90 Unknown Unknown 2 NCTC 9529 United Kingdom Water 16
93 Unknown Unknown 1 NCTC 9238 United Kingdom Human (abdominal pus) 1
102 Unknown Unknown 2 NCTC 9844 United Kingdom Unknown 10
107 Unknown Unknown 1 ATCC BAA 893 United States Milk powder 2
109 Unknown Unknown 1 ATCC BAA 894 United States Neonate 2
a Final product.
b Environmental.
c Intermediate product; PIF, powdered infant formula.
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Wizard Genomic DNA purification kit (Promega, Madison, WI) and quantified
using spectrophotometry (NanoDrop). The integrity of the purified template
DNA was assessed by conventional agarose gel (1% [wt/vol]) electrophoresis,
and the DNA preparations were stored at 4°C.
Identification of TRs. The TR DNA motifs were identified from version 4 of
a 6.4 covered draft genome sequence of E. sakazakii ATCC BAA-894 using
Tandem Repeats Finder software (3; http://tandem.bu.edu/trf/trf.html). A large
number of TRs were identified, and a selection of these were initially assessed for
their potential value in a typing scheme. Loci were chosen based on the following
features: copy number and repeat units that were both practical in size and free
of nucleotide errors. PCR primers flanking the selected TRs were designed using
the Primer 3 website (http://frodo.wi.mit.edu/). Care was taken to generate
primers with similar or identical melting temperatures that provided a single
distinct amplicon at each locus. Initially, the size variation and utility of particular
TR loci were assessed across a subset of E. sakazakii isolates and analyzed by
conventional agarose gel electrophoresis. Using this approach, four novel loci
were selected and taken forward for full assessment (Table 2). All four of these
VNTRs (denoted Enterobacter sakazakii tandem repeat 1 [ESTR-1] through -4)
were localized in intergenic regions of the E. sakazakii genome and contained
repeat motifs ranging from 7 to 15 base pairs.
MLVA PCR amplification. All four selected MLVA loci were amplified indi-
vidually by PCR. The reaction mixtures consisted of 1 PCR buffer containing
1.5 mM MgCl2 (New England Biolabs, United Kingdom), 100 mM deoxynucleo-
side triphosphates, 0.1 M dye-labeled forward primer (MWG Biotech AG,
Ebersberg, Germany), 0.1 M nonlabeled reverse primer, 2.5 U Taq DNA
polymerase (New England Biolabs, United Kingdom), 100 ng template DNA,
and PCR grade water (Invitrogen, California) in a volume of 50l. Forward primers
were fluorescently labeled with 4,7,2,7-tetrachloro-[3,6-dipivaloylfluoresceinyl]-6-
carboxamidohexyl]-1-O-[2-cyanoethyl]-[N,N-diisopropyl]-phosphoramidite] (TET), 3,
6-dipivaloylfluoresceinyl-6-carboxamidohexyl-1-O-2-cyanoethyl-N,N-diisopropyl-
phosphoramidite (FAM), or 4,7,2,4,5,7-hexachloro-3,6-dipivaloylfluoresceinyl-6-
carboxamidohexyl-1-O-2-cyanoethyl-N,N-diisopropyl-phosphoramidite (HEX) (Table
3). The thermal amplification conditions were 95°C for 1 min, followed by 35 cycles of
94°C for 1 min, 52°C for 1 min, and 72°C for 1 min, with a final extension of 72°C for 5
min. Following amplification, equal volumes (2l) from each of the four individual PCR
mixtures (ESTR-1 to4) were electrophoresed on a 1% (wt/vol) agarose gel at 100 V
for 90 min in 1Tris-borate-EDTA. The band intensity of each amplicon was examined
prior to GeneScan analysis. All four loci were amplified two or three times from each
isolate to ensure reproducibility.
MLVA. Prior to GeneScan analysis, amplicons of uniform intensity were diluted
1:100 in distilled water. For each individual isolate, 1 l of the diluted amplified
product for each locus was added to a fresh tube. One microliter of this pooled
mixture was added to the following: 2.5l deionized formamide, 0.5l of EDTA (50
mM; pH 8.0)/blue dextran (50 mg/ml) loading dye (Applied Biosystems, Foster City,
CA), and 1 l of GeneFLO tetramethylcarboxyrhodamine (TAMRA)-labeled 625
DNA Ladder (Chimerx, Madison, WI). This mixture was denatured at 92°C for 5
min and immediately placed on ice. An aliquot of the final mixture (3 l) was loaded
and electrophoresed at 3,000 V, 60 mA, and 200 W for 1.5 h at 52°C on an ABI 377
DNA analyzer (Applied Biosystems, Foster City, CA) using a 5% (wt/vol) Long-
Ranger denaturing acrylamide gel (Cambrex, Nottingham, United Kingdom). The
dyes were detected using filter set C, a filter set suitable for the detection of the dyes
HEX, TAMRA, FAM, and TET. Following electrophoresis, sample lanes were
tracked and extracted. Size values were assigned to the GeneFlo TAMRA-labeled
625 DNA ladder. Other dye-labeled fragments were sized relative to these, using
GeneScan analysis software, version 3.1.2.
The analysis parameters on the GeneScan analysis software settings were set
as follows. The data point range was set from 1,250 to 10,000. The baseline line
and multicomponent data-processing tools were selected, and the peak ampli-
tude thresholds were set as follows: green, 50; blue, 50; black, 50;, and red, 5. The
peak half-width was set at two points, all sizes were selected in the size call range,
the local Southern size-calling method was selected, and finally, the split-peak
correction was set at the leftmost peak, with a correction limit of 30 data points.
Following analysis, correct sizing of the doublets contained within the GeneFLO
TAMRA-labeled 625 DNA ladder was checked.
Data analysis. A four-digit allele string based on the number of repeats was
assigned to all isolates in the following order: ESTR-1, ESTR-2, ESTR-3, and
ESTR-4. One hundred and seven allele strings were imported into a Bionumerics
software package (version 4.5; Applied Maths, Sint-Martens-Latem, Belgium)
and a minimum-spanning tree (MST) was generated based on the categorical
and the priority rule highest number of single-locus variants (where two types
were at equal distances from the tree, the type with the highest number of
single-locus variants was linked first).
PFGE and analysis. All isolates were typed by PFGE using methods previously
described by Mullane et al. (28). DNA fingerprints were stored as tagged image
format files and imported into BioNumerics software (Applied Maths, Sint-Martens-
Latem, Belgium), where a dendrogram was created using the DICE coefficient and
the unweighted pair group method with arithmetic mean. A position tolerance of
1.5% and optimization of 1.5% were applied. The genetic diversity and relatedness
of the E. sakazakii isolates were compared at 80% similarity.
Sequence verification and diversity. To confirm that length polymorphisms
were the result of repeat copy number variation, a subset of amplicons were
purified with a Qiagen MiniElute gel extraction kit (Qiagen, Hilden, Germany),
and DNA sequencing was performed on PCR products representing at least two
alternative alleles for all four novel VNTR loci. Each PCR product was se-
quenced in both directions (GATC, Constance, Germany), and sequence infor-
mation was analyzed with DNAStar (DNAStar, Madison, WI).
The genetic diversity of TRs for each locus was calculated using Simpson’s
TABLE 2. Selected VNTR loci in the E. sakazakii BAA-894 genomea
Locus TR sequence (5–3) Gene % GC content Contig no. Location on contig (nt)
ESTR-1 GTTGAGGTGGCGGGT Intergenic region 67 1.19 86316–86346
ESTR-2 TTTGAGGCGAACG Intergenic region 54 0b 501708–501744
ESTR-3 GACCGCA Intergenic region 71 0b 1207159–1207222
ESTR-4 GGCTGCGGTTTTTCG Intergenic region 60 1b 153842–153872
a See http://genome.wustl.edu/pub/organism/Microbes/Enteric_Bacteria/Enterobacter_sakazakii/assembly/Enterobacter_sakazakii-4.0/.
b TR from sequence information from supercontigs.
TABLE 3. Primers for PCR amplification of selected VNTR used in this study
Locus Primer Primer sequence (5–3) Productsize (bp)a
Annealing
temp (oC)
ESTR-1 ESTR1-F 5 TET-TCCGGCCATTTCGCTCTG 183 52
ESTR1-R 5 TTACAGCGGCCCGAATACTC
ESTR-2 ESTR2-F 5 FAM-AGGATAAAAATGCCGAGGGAATGT 309 52
ESTR2-R 5 TGGGCAACGATAAATCAAACACT
ESTR-3 ESTR3-F 5 HEX-CGAAGACGGGTGATGAAAAA 155 52
ESTR3-R 5 CAGGCGAATTCCTCTCTGTT
ESTR-4 ESTR4-F 5 HEX-GTGATACCGGCGTAATCCTG 384 52
ESTR4-R 5 GGCACCGCATAAAGAGAATG
a Size of product in absence of TR.
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index, while the discriminatory index of PFGE and MLVA was assessed using
Simpson’s index of diversity (10, 36).
RESULTS
For the development of this MLVA method, primers flank-
ing each locus were designed to amplify all four TR-containing
regions (ESTR-1, ESTR-2, ESTR-3, and ESTR-4). The am-
plified products were pooled for each isolate and then resolved
on a 377 DNA sequencer and sized using GeneScan analysis
software. The electropherogram of the pooled amplicons
showed a clear sizing pattern that was easily interpreted (Fig.
1). The VNTR loci from three isolates are shown, and the
internal size standard is displayed. The internal size standard
gave uniform peak spacing at 25-bp intervals up to 625 bp (Fig.
1). All loci were identified automatically by the software ac-
cording to their sizes and fluorescences. The use of multiple
dyes allowed ease of interpretation of the electopherogram in
cases where amplicons overlapped. An example of this is
shown in Fig. 1, where ESTR-1 and ESTR-3 of ATCC BAA-
894 differ by a single base pair. Isolate 80 and NCTC 8155
shared three loci but differed by a single repeat motif at ESTR-3,
while ATCC BAA-894 differed at all four loci (Fig. 1).
Nucleotide sequencing of each of the four amplified loci
from two isolates confirmed that size polymorphisms were due
to varying repeat units. An example of this is shown in Fig. 2a,
where the size variation in the amplicons from the ESTR-3 loci
in CFS1001 and NCTC 8155 can be attributed to the presence
of eight and four TRs, respectively. Figure 2b shows a selection
of 10 alleles varying in size from 168 bp containing 2 repeats to
245 bp containing 13 repeats.
MLVA was used to genotype a geographically diverse and
previously characterized collection of 112 E. sakazakii isolates
from clinical, food, and environmental origins representing all
16 currently identified biogroups. Excluding null-allele types, a
range of 2 to 14 alleles was found for the four loci, with VNTRs
repeating from 0 times (absence of a repeat unit) at some loci
up to 19 times at others (ESTR-3). ESTR-3 was the most
variable locus, displaying 14 alleles with repeat copy numbers
ranging from 1 to 19. A summary of the allelic variability of the
loci is given in Table 4. The diversity index, which reflects the
value of a TR locus for the purpose of typing, was calculated in
each case using Simpson’s index. These values ranged from
61.0 to 89.7% (Table 4). Five isolates (E888, E866, E515, E616,
and E694) failed to produce amplicons at any of the four loci.
These isolates were excluded from further study but were in-
cluded in PFGE analysis.
The genetic relationships of 107 of the 112 isolates were
deduced by the construction of an MST (Fig. 3). Forty-nine
unique allele strings were observed among these isolates. The
MST highlights the diversity among the tested isolates. A num-
ber of branched clusters were visible, but no association could
be established between the isolate type, geographical origin, or
biogroup (Fig. 3).
Figure 4 shows a PFGE dendrogram of all isolates with
corresponding MLVA allele strings. A total of 49 MLVA and
64 PFGE types were identified among the 107 isolates analyzed
(Fig. 3 and 4). The discriminatory indices of the two methods,
calculated using Simpson’s diversity index, were 0.960 and
0.981 for MLVA and PFGE, respectively. This indicates that if
two isolates are sampled randomly from a collection and ana-
lyzed by MLVA, then 96% of the samples would fall into
different types.
FIG. 1. E. sakazakii GeneScan traces generated from four dye-labeled VNTR loci showing three different profiles. The red peaks are the
GenFLO TAMRA-labeled internal size standards. ESTR-2 was labeled with FAM (blue peak), ESTR-3 and ESTR-4 loci were labeled with HEX
(black peaks), and the ESTR-1 locus was labeled with TET (green peak). The size of each locus is indicated in the three windows of isolates NCTC
8155 (top), 80 (middle), and ATCC BAA-894 (bottom).
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The PFGE dendrogram identified 23 clusters containing
from 2 to 11 isolates that displayed 80% similarity (Fig. 4).
The same allele string was assigned to 16 of these clusters, 7 of
which were represented by unique allele strings. The allele
strings assigned to the remaining nine clusters were shared
with isolates of different PFGE types. Conversely, seven PGFE
clusters were subdivided into different MLVA types. The larg-
est cluster, cluster A (n  11), consisting of isolates from an
infant milk powder production facility and clustering at 80%
similarity by PFGE, shared the same allele identifier
(02.03.08.02) by MLVA. The conservation of the allele string
in these isolates sampled over a 1-year period demonstrates
the stability of each locus over time. Cluster B shared 77%
similarity with cluster A; however, MLVA failed to make a
distinction between the two groups. Furthermore, isolate E784,
which was associated with neonatal infection in The Nether-
lands, was also assigned the allele string 02.03.08.02, although
it shared only 64% similarity with the isolates from the pro-
duction factory. Two different allele codes were assigned to
isolates in cluster C (n 5), which were also obtained from the
same infant milk powder production facility. Of these, the
allele string 05.01.05.01 was shared with isolates E892 and 80,
which are represented by different PFGE pulse types. Simi-
larly, allele code 05.01.06.01 was shared with isolates CFS148,
CFS173, E830, 50, 82, and 343, which are associated with four
different PFGE types. The PFGE types of these isolates
showed between 58 and 74% similarity with cluster C. PFGE
cluster D contained isolates that were epidemiologically linked
to cases of meningitis in 2004 (31). These were all given the
same allele identifier by MLVA. This identifier was also
shared with isolate 109 of unknown origin and the clonally
related isolates E787 and E786, which showed 78 and 52%
similarity to the cluster, respectively. The other subtype
implicated in the New Zealand 2004 case (cluster E) was
successfully grouped by this method. The two clonal isolates,
E837 and E844, involved in an outbreak in France (cluster
F) displayed the same allele string, while the other two
implicated isolates (E834 and E846), in agreement with
PFGE, gave different allele identifiers.
DISCUSSION
A greater understanding of the routes of E. sakazakii con-
tamination of powdered infant formula facilities would signif-
icantly reduce the risk of infection among vulnerable groups.
The availability of rapid and accurate surveillance tools would
FIG. 2. (a) Sequencing alignment of ESTR-3 loci from isolates CFS1001 and NCTC8155. The result from sequencing shows that the amplified
fragment size variation at the loci between isolates CFS1001 (top) and NCTC8155 (bottom) is due to different numbers of -GACCGCA- repeats
alone. The arrows indicate primer binding sites. (b) Agarose gel image of ESTR-3 from strains NCTC 8155 (182-bp product) (lane 1), CFS1001
(210-bp product) (lane 2), 82 (196-bp product) (lane 3), 102 (245-bp product) (lane 4), ATCC BAA-894 (217-bp product) (lane 5), 73 (182-bp
product) (lane 6), 338 (217-bp product) (lane 7), 336 (203-bp product) (lane 8), 344 (168-bp product) (lane 9), and 109 (203-bp product) (lane 10).
Lanes M, 100-bp molecular size marker (New England Biolabs, England).
TABLE 4. MLVA locus characteristics
Locus







ESTR-1 0 9 9 32 75.8
ESTR-2 0 3 4 12 74.7
ESTR-3 1 19 14 16 89.7
ESTR-4 1 2 2 11 61.0
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enable the development of more targeted and effective control
strategies to provide a safer powdered product. This approach
would also be of value when applied in clinical and care set-
tings to support epidemiological investigations. Controlling the
processing environment by exclusion of E. sakazakii remains a
significant challenge for those producing infant formula pow-
der. Carefully developed Hazard Analysis and Critical Control
Point plans could benefit from a clearer description of the
epidemiology of the organism in the powdered infant formula
production environment, as previously shown by Mullane et
al., (28). Molecular typing remains an important tool for sur-
veillance, outbreak investigation, and tracing of bacteria
through the food chain. The ability to trace E. sakazakii is of
epidemiological importance because of the implications for
infant health and of economic value to infant formula produc-
ers. No standardized protocol to investigate the dissemination
of E. sakazakii has been agreed on. PFGE, along with other
subtyping strategies, has been applied (5, 8, 28, 30, 37). Despite
the apparent advantages of PFGE, the approach will not
evolve technically in the future. Therefore, molecular biolo-
FIG. 3. (a) MST of MLVA (where the weight of the edge between each pair of points is the distance between those two points) analysis of 107
isolates of E. sakazakii. (b) MST of MLVA analysis showing biogroup identities of each cluster.
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FIG. 4. Dendrogram of the 112 isolates that were previously typed by XbaI PFGE. Allele strings and biogroups are also included. The arrow
indicates isolate E784.
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gists have begun to assess the utility of second-generation
subtyping methods. MLVA is one such approach. In this pa-
per, we have described the development and application of an
MLVA typing protocol for E. sakazakii. A set of four discrim-
inatory TR markers were identified and used in the develop-
ment of the typing scheme.
Our method was applied to 112 previously characterized E.
sakazakii isolates representing all 16 biogroups. The study col-
lection was cultured from clinical, food, and environmental
sources from diverse geographical origins. In addition, a num-
ber of strains from a narrower population, all originating from
the one infant formula production facility, were included to
assess the method’s ability to identify clonal populations (28).
A virtually continuous range of repeats was observed across
the four loci, suggesting a well-balanced diversity among the
isolates in the study. Stability of a given MLVA type over a
1-year period was shown. Although the Simpson’s indices cal-
culated for PFGE and MLVA were similar, more subtypes
could be identified by PFGE, indicating the higher discrimina-
tory power of this method when applied to this collection of
isolates. Nonetheless, MLVA grouped together all of the
clonal isolates identified by PFGE in cluster A. Failure to
discriminate between the clonally related isolates in cluster A
and cluster B could possibly be due to incomplete XbaI diges-
tion, resulting in one- or two-band differences. MLVA clus-
tered isolates obtained from a recent outbreak in New Zealand
and clearly distinguished them from isolates from an unrelated
French outbreak that occurred later. However, identical
MLVA types from the New Zealand outbreak were also found
among nonrelated isolates, and one nonrelated isolate in clus-
ter A had the same allele code as isolates in this cluster.
Including all 112 isolates, we noted that TR amplicons were
absent for 31% of the strains at ESTR-1, 11% at ESTR-2, 15%
at ESTR-3, and 10% at ESTR-4. Failure of amplification of
TR loci is mainly attributable to polymorphisms in the primer-
annealing site(s) that flank the TR or to absence of the corre-
sponding locus in some strains. Bearing in mind that E. saka-
zakii is poorly defined taxonomically and may represent more
than one species, amplification failure of all loci may reflect the
diversity of the species being typed. Recently, it has been pro-
posed that E. sakazakii be reclassified as four species, one geno-
mospecies, and two subspecies in a new genus “Cronobacter”
within the family Enterobacteriaceae (12). Using this classification
system, “C. sakazakii” comprises biogroups 1 to 4, 7, 8, 11, and 13.
The other species are represented by biogroups 5, 6, 9 10, 12, and
14 to 16. Excluding all strains (n  20) belonging to these bio-
groups from MLVA analysis, fewer amplification failures were
noted at all loci: 10% at ESTR-1, 0% at ESTR-2, 2% at ESTR-3,
and 3% at ESTR-4. As our primers were designed based on
ATCC BAA-894 (the only available genome sequence), which
belongs to “C. sakazakii,” these findings support the reclassifica-
tion of the species as described by Iversen et al. (12). However,
use of TR motifs to examine taxonomy in bacteria is open to
criticism, largely due to concerns in relation to rapid evolution
and possible homoplasty that could potentially result in mislead-
ing conclusions (42).
In this study, no relationship between the geographical ori-
gin and conservation of particular allele motifs could be estab-
lished. Allelic relationships could perhaps develop following
analysis of other collections and when a reference set of vari-
able loci has been established.
In conclusion, we have described the development and ap-
plication of an MLVA method to subtype E. sakazakii. Al-
though this method has less discriminatory power than PGFE,
it could potentially be used to rapidly monitor clonal outbreaks
of the organism in food production facilities. It is realistic to
assume that the inclusion of additional polymorphic loci would
further increase the discriminatory power of the method.
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